Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptolide Wilfordii for Immune Recovery in HIV
NCT03403569Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2018
- Primary completion
- Jun 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triptolide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Peking Union Medical College Hospital. Started Sep 2018; status: completed.
02
Drugs
triptolide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03403569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03403569.